RT Book, Section
A1 Bauer, Larry A.
SR Print(0)
ID 1115557286
T1 Lidocaine
T2 Applied Clinical Pharmacokinetics, 3e
YR 2015
FD 2015
PB McGraw-Hill Medical
PP New York, NY
SN 9780071794589
LK accesspharmacy.mhmedical.com/content.aspx?aid=1115557286
RD 2024/04/19
AB Lidocaine  is  a  local  anesthetic  agent  that  also  has  antiarrhythmic  effects.  It  is  classified  as  a  type  IB  antiarrhythmic  agent  and  is  a  treatment  for  ventricular  tachycardia.1,2  For  episodes  of  sustained  ventricular  tachycardia  with  signs  or  symptoms  of  hemodynamic  instability  (angina,  pulmonary  edema,  hypotension,  hemodynamic  collapse),  electrical  cardioversion  is  the  treatment  of  choice.  However,  for  patients  who  are  hemodynamically  stable,  sustained  monomorphic  ventricular  tachycardia  may  be  successfully  treated  using  antiarrhythmic  therapy.  Lidocaine  therapy  is  considered  an  alternative  to  procainamide,  amiodarone,  or  sotalol  treatment  in  this  situation.3